Potential Tool To Capture Circulating Cancer Cells

A modified opsonin bound to antibody (FcMBL) could become a broad-spectrum potent tool in the treatment of several cancer types by binding to carbohydrate ligands on the surface of cancer cells, according to a recent study conducted at the Wyss Institute at Harvard University.

Related Links